| Melissa Cruz Azarraga, | |
|
2485 El Camino Real, T-0321, Redwood City, CA 94063-2849 | |
| (650) 549-0000 | |
| (650) 480-5816 |
| Full Name | Melissa Cruz Azarraga |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2485 El Camino Real, Redwood City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144575101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 67158 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Cruz Azarraga, 2485 El Camino Real, T-0321, Redwood City, CA 94063-2849 Ph: (650) 549-0000 | Melissa Cruz Azarraga, 2485 El Camino Real, T-0321, Redwood City, CA 94063-2849 Ph: (650) 549-0000 |
News Archive
Findings from clinical studies used to gain Food and Drug Administration approval of common antidepressants are not applicable to most patients with depression, according to a report led by the University of Pittsburgh Graduate School of Public Health.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
Researchers at the UCLA Medical Center found that antiviral therapy during compensated cirrhosis, when compared with all other strategies, is the most cost-effective approach to treating patients with advanced liver disease due to hepatitis C infection. Full details appear in the June issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
GTx, Inc. (Nasdaq: GTXI), today announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN), a precancerous lesion of the prostate.
iScreen Vision, Inc. (www.iscreenvision.com), a leading provider of pediatric vision screening equipment and services, today announced it raised $4.0 million in a Series B funding round led by MB Venture Partners.
› Verified 2 days ago
Dr. Bobbi Lynn Sharafi, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 850 Woodside Rd, Redwood City, CA 94061 Phone: 650-365-2522 | |
Patricia Ko, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 Veterans Blvd, Redwood City, CA 94063 Phone: 650-299-3004 | |
Dr. Danny S Lee, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 Veterans Blvd, Redwood City, CA 94063 Phone: 650-299-3567 Fax: 650-299-2672 | |
Antoine Dang, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 Veterans Blvd, Redwood City, CA 94063 Phone: 650-299-2000 | |
Mrs. Linh P Wong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 Marshall St # 118, Redwood City, CA 94063 Phone: 650-299-2619 | |
Jenny Huang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 270 Redwood Shores Pkwy, Redwood City, CA 94065 Phone: 650-631-1685 | |
Kirstin Lynn Kim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 Veterans Blvd, Redwood City, CA 94063 Phone: 650-299-3581 |